![](/img/cover-not-exists.png)
DACLIZUMAB PERMITS DELAYED INTRODUCTION OF CALCINEURIN INHIBITORS IN RENAL TRANSPLANT RECIPIENTS AT RISK FOR DELAYED GRAFT FUNCTION.
Golconda, Muralikrishna S., Rayhill, Stephen C., Hunsicker, Lawrence G.Volume:
69
Journal:
Transplantation
DOI:
10.1097/00007890-200004271-00175
Date:
April, 2000
File:
PDF, 976 KB
2000